HL

Henry B. Lowman

CT Cytomx Therapeutics: 3 patents #5 of 28Top 20%
Overall (2021): #81,537 of 548,734Top 15%
3
Patents 2021

Issued Patents 2021

Patent #TitleCo-InventorsDate
11180562 Method of treating or delaying progression of an epidermal growth factor receptor (EGFR)-related disorder by administering activatable EGFR-binding antibodies Luc Desnoyers, Shouchun Liu 2021-11-23
11161906 Multispecific antibodies, multispecific activatable antibodies and methods of using the same James William West, Sherry Lynn La Porte, Bryan Irving, Daniel Robert Hostetter, Chihunt Wong 2021-11-02
10894821 Activatable antibodies having non-binding steric moieties and methods of using the same Shouchun Liu 2021-01-19